tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

NPCE Stock Latest News

NeuroPace price target lowered to $13 from $15 at Wells Fargo
The FlyNeuroPace price target lowered to $13 from $15 at Wells Fargo
9d ago
NPCE
NeuroPace, Inc. Reports Strong Q3 2024 Results
PremiumCompany Announcements
NeuroPace, Inc. Reports Strong Q3 2024 Results
9d ago
NPCE
NeuroPace reports Q3 EPS (19c), consensus (27c)
PremiumThe Fly
NeuroPace reports Q3 EPS (19c), consensus (27c)
9d ago
NPCE
NeuroPace raises FY24 revenue view to $78M-$80M from $76M-$78M
PremiumThe Fly
NeuroPace raises FY24 revenue view to $78M-$80M from $76M-$78M
9d ago
NPCE
NPCE Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
NPCE Upcoming Earnings Report: What to Expect?
12d ago
NPCE
NeuroPace submits safety, effectiveness data from RNS System study to FDA
PremiumThe FlyNeuroPace submits safety, effectiveness data from RNS System study to FDA
17d ago
NPCE
NeuroPace price target lowered to $15 from $20 at Wells Fargo
Premium
The Fly
NeuroPace price target lowered to $15 from $20 at Wells Fargo
3M ago
NPCE
NeuroPace raises FY24 revenue view to $76M-$78M from $73M-$77M
Premium
The Fly
NeuroPace raises FY24 revenue view to $76M-$78M from $73M-$77M
3M ago
NPCE
NeuroPace reports Q2 EPS (26c), consensus (30c)
PremiumThe Fly
NeuroPace reports Q2 EPS (26c), consensus (30c)
3M ago
NPCE
NPCE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
NPCE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
NPCE
NeuroPace price target lowered to $8 from $9.50 at Morgan Stanley
PremiumThe Fly
NeuroPace price target lowered to $8 from $9.50 at Morgan Stanley
4M ago
NPCE
Lake Street highlights five ‘bargain bin’ small cap healthcare ideas for 2H
PremiumThe Fly
Lake Street highlights five ‘bargain bin’ small cap healthcare ideas for 2H
4M ago
AORT
LNSR
NeuroPace post Q1 move ‘overdone,’ says Lake Street
PremiumThe FlyNeuroPace post Q1 move ‘overdone,’ says Lake Street
6M ago
NPCE
Neuropace’s Financial Health: Navigating Risks Tied to RNS System Dominance and Supplier Dependencies
Premium
Company Announcements
Neuropace’s Financial Health: Navigating Risks Tied to RNS System Dominance and Supplier Dependencies
7M ago
NPCE
Neuropace Inc trading resumes
Premium
The Fly
Neuropace Inc trading resumes
7M ago
NPCE
Neuropace Inc trading halted, volatility trading pause
PremiumThe Fly
Neuropace Inc trading halted, volatility trading pause
7M ago
NPCE
NeuroPace sees FY24 revenue $73M-$77M, consensus $75.2M
PremiumThe Fly
NeuroPace sees FY24 revenue $73M-$77M, consensus $75.2M
7M ago
NPCE
NeuroPace reports Q1 EPS (32c), consensus (32c)
PremiumThe Fly
NeuroPace reports Q1 EPS (32c), consensus (32c)
7M ago
NPCE
‘Time to Hit Buy,’ Says Wells Fargo About These 2 Stocks
PremiumStock Analysis & Ideas
‘Time to Hit Buy,’ Says Wells Fargo About These 2 Stocks
8M ago
GDRX
NPCE
Wells Fargo upgrades NeuroPace to Overweight, raises price target to $20
PremiumThe FlyWells Fargo upgrades NeuroPace to Overweight, raises price target to $20
8M ago
NPCE
NeuroPace upgraded to Overweight from Equal Weight at Wells Fargo
Premium
The Fly
NeuroPace upgraded to Overweight from Equal Weight at Wells Fargo
8M ago
NPCE
Neuropace, Inc.’s New Economy & Political Environment Risk – A Cause for Worry?
Premium
Company Announcements
Neuropace, Inc.’s New Economy & Political Environment Risk – A Cause for Worry?
9M ago
NPCE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >